Neutron Therapeutics Ships Third High Flux Neutron Source

Tuesday, 15th February 2022 – Danvers, Massachusetts

We are excited to share that our latest High Flux Accelerator-Driven Neutron Source has just left our loading dock in Danvers, destined for the University of Birmingham! Installation will begin in March.

The facility will be part of the UK’s National Nuclear User Facility (NNUF) and will enable a wide range of research projects requiring a reliable neutron source, ranging from nuclear medicine to materials science to space applications.

Neutron Therapeutics is proud to be a part of this exciting project!


For further information, please contact:

Elizabeth Reczek, PhD, Chief Executive Officer, Neutron Therapeutics Inc.
Telephone: +1 617-216-3937